Quick Answer
Envoy Medical, Inc. reported R&D Expense of $12.49 million for fiscal year 2025.
Envoy Medical, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $12.49M | +22.7% |
| 2024 | $10.18M | +13.7% |
| 2023 | $8.96M | +80.0% |
| 2022 | $4.97M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.70M | -2.1% | +8.7% |
| June 30, 2025 | $2.48M | -4.1% | -9.6% |
| March 31, 2025 | $2.75M | +16.4% | -0.3% |
| September 30, 2024 | $2.76M | +49.0% | +6.4% |
| June 30, 2024 | $2.59M | +20.3% | +9.8% |
| March 31, 2024 | $2.36M | +22.5% | +27.6% |
| September 30, 2023 | $1.85M | +97.9% | -14.1% |
| June 30, 2023 | $2.15M | — | +11.7% |
- Envoy Medical, Inc. showed an increase of +22.7% in R&D Expense compared to the prior fiscal year.
- Over the 2022–2025 period, Envoy Medical, Inc.’s r&d expense has grown by 151.0% (from $4.97 million to $12.49 million).
- The most recent figure is from Envoy Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: